申请人:Kanebo, Ltd.
公开号:US05912247A1
公开(公告)日:1999-06-15
A quinazoline compound of the formula (I): ##STR1## wherein Z means a group of the formula: ##STR2## (X is CH.sub.2, CHOH, CHOCH.sub.3, or O, and n is 1 to 3), or a group of the formula: ##STR3## (A is H or CH.sub.3, and B is --CH.sub.2 OH, or ethyl having 1 or 2 OH, or propyl having 2 or 3 OH), or a salt thereof, which are useful as anti-tumor agent, and a pharmaceutical composition containing the compound as an active ingredient.
一种喹唑啉化合物,其化学式为(I):##STR1## 其中Z表示以下式的基团:##STR2## (其中X为CH.sub.2,CHOH,CHOCH.sub.3或O,n为1到3),或以下式的基团:##STR3## (其中A为H或CH.sub.3,B为--CH.sub.2 OH,或具有1或2个OH的乙基,或具有2或3个OH的丙基),或其盐,其作为抗肿瘤剂有用,以及含有该化合物作为活性成分的制药组合物。